DrugPatentWatch Database Preview
Drugs in Development Information for Zidebactam
» See Plans and Pricing
What is the drug development status for Zidebactam?
Zidebactam is an investigational drug.
There have been 4 clinical trials for Zidebactam.
The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.
The most common disease conditions in clinical trials are Renal Insufficiency and [disabled in preview]. The leading clinical trial sponsors are Wockhardt, Quintiles, Inc., and Clinartis.
There are seven US patents protecting this investigational drug and sixty-five international patents.
Summary for Zidebactam
| US Patents | 7 |
| International Patents | 65 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 11 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2016-02-01) |
| Vendors | 7 |
Recent Clinical Trials for Zidebactam
| Title | Sponsor | Phase |
|---|---|---|
| Plasma and Intrapulmonary Concentrations Study of WCK 5222 | Wockhardt | Phase 1 |
| To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment | Clinartis | Phase 1 |
| To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment | Wockhardt | Phase 1 |
Clinical Trial Summary for Zidebactam
Top disease conditions for Zidebactam
Top clinical trial sponsors for Zidebactam
US Patents for Zidebactam
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Zidebactam | Start Trial | Pharmaceutical compositions comprising antibacterial agents | WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN) | Start Trial |
| Zidebactam | Start Trial | Nitrogen containing compounds | Wockhardt Ltd. (Bandra-Kurla Complex, Bandra East, Mumbai, IN) | Start Trial |
| Zidebactam | Start Trial | Compositions and methods for treating bacterial infections | WOCKHARDT LIMITED (Chikalthana, IN) | Start Trial |
| Zidebactam | Start Trial | Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane | WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN) | Start Trial |
| Zidebactam | Start Trial | Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbon- yl]-1,6-diaza-bicyclo[3.2.1] octane | WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN) | Start Trial |
| Zidebactam | Start Trial | Pharmaceutical compositions comprising antibacterial agents | WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Zidebactam
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Zidebactam | Australia | AU2015208830 | 1989-12-31 | Start Trial |
| Zidebactam | Canada | CA2954553 | 1989-12-31 | Start Trial |
| Zidebactam | European Patent Office | EP3217979 | 1989-12-31 | Start Trial |
| Zidebactam | India | IN193MU2014 | 1989-12-31 | Start Trial |
| Zidebactam | Russian Federation | RU2017110457 | 1989-12-31 | Start Trial |
| Zidebactam | World Intellectual Property Organization (WIPO) | WO2015110950 | 1989-12-31 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
